|
WO2012066248A1
|
|
Air-permeable adaptable mouthguard having clamped jaws
|
|
HK1140530A1
|
|
Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
|
|
WO2010133652A1
|
|
Multimodal activity of g-quartet oligonucleotides and microbicide compositions
|
|
WO2010063847A1
|
|
Compositions for potentiating apoposis signals in tumour cells
|
|
EP2364299A1
|
|
Bis [o-(14-benzoylaconine-8-yl)]esters
|
|
US2009318413A1
|
|
Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma
|
|
CA2706812A1
|
|
Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
|
|
CA2684015A1
|
|
Method for preparing a substrate for immobilising a cell, said substrate and uses thereof
|
|
EP2050441A1
|
|
Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
|
|
EP2021482A1
|
|
Treatment of an infection by an rna virus due to an rna dependent rna polymerase
|
|
WO2007125225A1
|
|
Modelling in yeast of the mitochondrial atp6 gene mutations responsible for narp syndrome in humans and uses thereof for screening for medicaments
|
|
WO2006111687A1
|
|
Device for evaluating a person's physical fitness
|
|
FR2891993A1
|
|
COMPOSITION FOR PHYTOPHARMACEUTICAL APPLICATION FOR STIMULATING THE NATURAL DEFENSES OF PLANTS
|
|
EP0242244A1
|
|
Pharmaceutical composition consisting of a calcium carbonate suspension
|
|
US4765992A
|
|
Stimulation of alcoholic fermentation by adsorption of toxic substances with cell walls
|
|
PT78640A
|
|
Process for simulation of alcoholic fermentation of a substratum
|
